Patrizia Casalini Selected Research

Patrizia Casalini Research Topics

Disease

27	Neoplasms (Cancer) 01/2019 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2002
4	Carcinoma (Carcinomatosis) 06/2014 - 07/2004
3	Triple Negative Breast Neoplasms 01/2016 - 08/2012
3	Carcinogenesis 03/2009 - 09/2004
2	Inflammation (Inflammations) 04/2018 - 12/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Hypoxia (Hypoxemia) 04/2018
1	Starvation 04/2018
1	Iron Deficiencies 04/2018
1	Adenocarcinoma 01/2018
1	Disease Progression 06/2014
1	Neoplastic Processes 05/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Vasculitis (Vasculitides) 10/2012
1	Fibrosis (Cirrhosis) 12/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2011
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 10/2011
1	medullary Thyroid cancer 10/2011
1	Angiosarcoma of the breast 11/2010
1	Myxoid Liposarcoma 07/2010
1	Neoplasm Metastasis (Metastasis) 01/2008
1	Ovarian Neoplasms (Ovarian Cancer) 09/2007
1	Ovarian Epithelial Carcinoma 09/2007

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 06/2018 - 09/2007
7	Proteins (Proteins, Gene)FDA Link 05/2018 - 03/2004
4	Phosphotransferases (Kinase)IBA 10/2011 - 09/2004
3	Messenger RNA (mRNA)IBA 01/2019 - 12/2008
3	Pharmaceutical PreparationsIBA 06/2018 - 01/2008
3	Monoclonal AntibodiesIBA 06/2014 - 01/2002
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 06/2018
2	human ERBB2 proteinIBA 01/2019 - 02/2003
2	Biomarkers (Surrogate Marker)IBA 06/2018 - 10/2011
2	LipidsIBA 04/2018 - 10/2011
2	Epidermal Growth Factor (EGF)IBA 11/2015 - 05/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2014 - 02/2003
2	CollagenIBA 06/2014 - 12/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011 - 05/2006
2	Oncogene Proteins (Oncogene Protein)IBA 10/2011 - 05/2006
2	3' Untranslated Regions (3' UTR)IBA 10/2011 - 12/2008
2	tyrosine receptor (receptor, tyrosine)IBA 07/2010 - 09/2004
2	Complementary DNA (cDNA)IBA 03/2004 - 01/2002
2	Hormones (Hormone)IBA 06/2003 - 02/2002
1	Toll-Like Receptor 3IBA 10/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Chelating AgentsIBA 04/2018
1	IronIBA 04/2018
1	Deferoxamine (Desferal)FDA LinkGeneric 04/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	CD40 Ligand (CD40L)IBA 01/2018
1	cadherin 5IBA 01/2017
1	fragile histidine triad proteinIBA 11/2015
1	Proteasome InhibitorsIBA 11/2015
1	matrigelIBA 06/2014
1	Liposomes (Liposome)IBA 06/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2014
1	SerpinsIBA 06/2014
1	SERPIN-B5 (maspin)IBA 06/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2012
1	indium-bleomycinIBA 12/2011
1	Cysteine (L-Cysteine)FDA Link 12/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011
1	Biological ProductsIBA 10/2011
1	Tyrosine (L-Tyrosine)FDA Link 10/2011
1	Caspase 8 (Caspase-8)IBA 10/2011
1	Death Domain ReceptorsIBA 10/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2010
1	TrabectedinIBA 07/2010
1	LigandsIBA 07/2010
1	RetinoidsIBA 12/2009
1	Estrogens (Estrogen)FDA Link 12/2009
1	Estrogen ReceptorsIBA 12/2009
1	FenretinideIBA 12/2009
1	4-oxofenretinideIBA 12/2009
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 04/2009
1	4- (5,6- dichloro- 1H- indol- 2- yl)- 3- ethoxy- N- (2,2,6,6- tetramethylpiperidin- 4- yl)benzamideIBA 01/2008
1	indoleIBA 01/2008
1	EnzymesIBA 01/2008
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2008
1	benzamideIBA 01/2008
1	Hyaluronic Acid (Hyaluronan)IBA 01/2008
1	AntigensIBA 10/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2007
1	Decitabine FDA Link 09/2007
1	DNA (Deoxyribonucleic Acid)IBA 09/2007
1	ErbB Receptors (EGF Receptor)IBA 09/2004
1	RNA (Ribonucleic Acid)IBA 03/2004
1	Glycoproteins (Glycoprotein)IBA 03/2004
1	Tamoxifen FDA LinkGeneric 06/2003
1	Therapeutic UsesIBA 02/2003

Therapy/Procedure

9	Therapeutics 01/2016 - 02/2003
2	Drug Therapy (Chemotherapy) 06/2014 - 07/2010
2	Radiotherapy 01/2013 - 07/2010
1	Molecular Targeted Therapy 05/2018
1	Immunotherapy 01/2018
1	Oral Administration 01/2008
1	Hysterectomy 06/2003
1	Adjuvant Chemotherapy 02/2003